Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Detrol LA add-on to alpha-blocker in men with persistent overactive bladder symptoms
2005-004452-13Phase 4Completed
- Sponsor
- Pfizer
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in overactive bladder (OAB) comparing Detrol LA add-on to alpha-blocker with Placebo add-on to alpha-blocker (2 arms). Primary endpoint: Improvement in Patient Perception of Bladder Condition at Week 12. Started Nov 2005; status: completed.
02
Drugs
tolterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on 2005-004452-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004452-13.